Completed PHASE4 INTERVENTIONAL 1-arm NCT02016391

Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours

Effects of Dexmedetomidine on Periprocedural Pain During Radiofrequency Ablation of Liver and Kidney Tumours

Sponsor: Uppsala University Hospital

Conditions Cancer of Kidney and Renal Pelvis Cancer of Liver

Updated 5 times since 2017 Last updated: Dec 16, 2014 Started: Dec 31, 2013 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cancer of Kidney and Renal Pelvis and Cancer of Liver, this trial is completed. The trial is conducted by Uppsala University Hospital and has accumulated 5 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Uppsala University Hospital

Data source: Uppsala University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Uppsala, Sweden